(PRWEB) June 05, 2015
The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4%. The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Browse 152 market data tables & 50 figures spread through 163 pages and in-depth TOC on “Interventional Cardiology & Peripheral Vascular Devices Market" is now available at @ http://www.rnrmarketresearch.com/interventional-cardiology-peripheral-vascular-devices-market-to-2016-embolic-protection-chronic-total-occlusion-coronary-atherectomy-thrombectomy-devices-ivus-angiography-catheters-evar-sten-market-report.html .
Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012.
The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes. The key players in Interventional Cardiology & Peripheral Vascular Devices Market includes Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Cordis Corporation, Medtronic, Inc, Spectranetics International BV, St. Jude Medical, Inc, Terumo Corporation and Terumo Corporation Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=56915 .
Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market. Priced at $4650 for a single user PDF, a discount on “Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) – Forecasts to 2019” research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=56915 .
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios of the top players in the interventional cardiology and peripheral vascular devices market. The report analyzes the interventional cardiology and peripheral vascular devices market by product and geography
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the interventional cardiology and peripheral vascular devices market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional cardiology and peripheral vascular devices market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various devices across geographies
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the interventional cardiology and peripheral vascular devices market
Related Market Report:
"Medical Videoscope Market by Scope [Rigid (Laparoscope, Ureteroscope), Flexible (Colonoscope, Gastroscope)], Visualization Systems (Monitors, HD Camera, 3D Camera, Light Source), by Application (Colonoscopy, Laparoscopy, Arthroscopy) – Global Forecasts to 2019” Companies profiled in this research report are Olympus Corporation, Stryker Corporation, Karl Storz GMBH & Co.KG, Fujifilm Holding Corporation, Hoya Corporation, Richard Wolf GMBH, Smith & Nephew PLC, Conmed Corporation, Welch Allyn, Inc and XION GMBH discussed in this research available at http://www.rnrmarketresearch.com/medical-videoscope-market-by-scope-rigid-laparoscope-ureteroscope-flexible-colonoscope-gastroscope-visualization-systems-monitors-hd-camera-3d-camera-light-source-by-application-colon-market-report.html .
Explore more Medical Devices Market Research Reports at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.